Center for Scientific Review; Notice of Closed Meetings, 66988 [E9-30021]
Download as PDF
<![CDATA[
66988
Federal Register / Vol. 74, No. 241 / Thursday, December 17, 2009 / Notices
Dated: December 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–30022 Filed 12–16–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Auditory Neuroscience.
Date: January 19–20, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: John Bishop, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–07–
420: Lymphatic Biology in Health and
Disease.
Date: January 27–28, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: Maqsood A. Wani, DVM,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114,
MSC 7814, Bethesda, MD 20892. 301–435–
2270, wanimaqs@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–30021 Filed 12–16–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Food and Drug Administration Clinical
Trial Requirements, Regulations,
Compliance and Good Clinical
Practices; Public Workshop
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public workshop.
SUMMARY: The Food and Drug
Administration (FDA) Florida District,
in cosponsorship with The Society of
Clinical Research Associates, Inc.
(SoCRA), is announcing a public
workshop entitled ‘‘FDA Clinical Trial
Requirements, Regulations, Compliance
and GCP.’’ This 2-day public workshop
is intended to provide information
about FDA clinical trial requirements to
the regulated industry.
Date and Time: The public workshop
will be held on Wednesday, March 3,
2010, from 8 a.m. to 5 p.m., and
Thursday, March 4, 2010, from 8 a.m. to
4:35 p.m.
Location: The public workshop will
be held at The Wyndham Orlando
Resort, 8001 International Dr., Orlando,
FL 32819, 407–351–2420.
Attendees are responsible for their
own accommodations. To make
reservations at the Wyndham Orlando
Resort, at the discounted rate of $149
per night (plus applicable taxes), contact
the hotel before February 10, 2010,
citing ‘‘SoCRA’’. The hotel’s Web site is:
https://www.wyndham.com/hotels/
MCOWD/main.wnt. (FDA has verified
the Web site address, but is not
responsible for subsequent changes to
the Web site after this document
publishes in the Federal Register.)
Contacts:
For FDA: C. Stewart Watson, Food
and Drug Administration, 555
Winderley Pl., suite 200, Maitland, FL
32751, 407–475–4756, FAX: 407–475–
4768, e-mail:
charles.watson@fda.hhs.gov.
For SoCRA: SoCRA Administrative
Office, 530 West Butler Ave., suite 109,
Chalfont, PA 18914, 1–800–762–7292 or
215–822–8644, FAX: 215–822–8633, email: SoCRAmail@aol.com.
Registration: You are encouraged to
register by February 26, 2010. Seats are
limited; please submit your registration
as soon as possible. Workshop space
will be filled in order of receipt of
registration. Registration will close
when the workshop is filled. Those
accepted into the workshop will receive
confirmation. Registration at the site is
not guaranteed but may be possible on
a space available basis on the day of the
public workshop beginning at 8 a.m.
The SoCRA registration fees cover the
cost of the workshop facilities,
materials, breaks, and lunches. The cost
of registration is as follows:
COST OF REGISTRATION
Affiliation
Fee
FDA Employee
Fee waived
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Federal Government (SoCRA Member)
$450.00
Federal Government (Non-SoCRA Member)
$525.00
Non-Federal Government (SoCRA Member)
$575.00
Non-Federal Government (Non-SoCRA Member)
$650.00
If you need special accommodations
due to a disability, please contact C.
VerDate Nov<24>2008
13:19 Dec 16, 2009
Jkt 220001
Stewart Watson at least 7 days in
advance of the meeting.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Registration instructions: To register,
please submit your name, affiliation,
E:\FR\FM\17DEN1.SGM
17DEN1
]]>Agencies
[Federal Register Volume 74, Number 241 (Thursday, December 17, 2009)]
[Notices]
[Page 66988]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30021]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Auditory Neuroscience.
Date: January 19-20, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting.)
Contact Person: John Bishop, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, bishopj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PAR-07-420: Lymphatic Biology in Health and Disease.
Date: January 27-28, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting.)
Contact Person: Maqsood A. Wani, DVM, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114, MSC 7814, Bethesda, MD
20892. 301-435-2270, wanimaqs@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: December 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-30021 Filed 12-16-09; 8:45 am]
BILLING CODE 4140-01-P
